Inventor

Jingrong Jean Cui

Inventor
San Diego, CA, US

Overview

31→
Patents
2003–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 31 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes17%
C07BGeneral methods of organic chemistry5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C07CAcyclic or carbocyclic compounds2%
C07KPeptides2%
Y02PClimate change mitigation technologies in the production or processing of goods1%
PatentTitleYear
10,745,416Macrocyclic compounds for treating disease202010,689,400Macrocycle kinase inhibitors202010,618,912Diaryl macrocycles as modulators of protein kinases202010,494,384Urea peptoid boric acid compound, pharmaceutical composition thereof, preparation method therefor, and uses thereof201910,316,044Chiral diaryl macrocycles as modulators of protein kinases201910,294,242Diaryl macrocycle polymorph201910,246,466Diaryl macrocycles as modulators of protein kinases20199,714,258'Diaryl macrocycles as modulators of protein kinases'20179,421,237'Tripeptide boronic acid or boronic ester, preparative method and use thereof'20169,328,096'Tropomyosin-related kinase inhibitors'20169,133,215'Macrocyclic derivatives for the treatment of diseases'20158,916,593'Alkoxy-substituted 2-aminopyridines as ALK inhibitors'20148,785,632'Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors'20148,680,111'Macrocyclic derivatives for the treatment of diseases'20148,217,057'Polymorphs of a c-MET/HGFR inhibitor'20128,106,197'Aminoheteroaryl compounds as protein kinase inhibitors'20127,858,643'Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors'20107,772,246'Pyrazole compounds as RAF inhibitors'20107,732,604'Triazolopyrazine derivatives'20107,250,417'Arylmethyl triazolo- and imidazopyrazines as c-Met inhibitors'20077,230,098'Aminoheteroaryl compounds as protein kinase inhibitors'20077,122,548'Triazolotriazine compounds and uses thereof'20067,105,562'Geometrically restricted 3-cyclopentylidene-1,3-dihydroindol-2-ones as potent protein tyrosine kinase inhibitors'20067,053,086'4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors'20067,037,909'Tetracyclic compounds as c-Met inhibitors'20066,908,930'4-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitors'20056,861,418'4-aryl substituted indolinones'20056,677,368'4-aryl substituted indolinones'20046,635,640'4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors'20036,610,688'4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors'20036,599,902'5-aralkysufonyl-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2007Patents assigned to SUGEN INC (12)· patent assignee history
2003–2006Based in Foster City, CA, US· patent location history
2005Based in Albany, CA, US· patent location history
2006–2020Based in San Diego, CA, US· patent location history
2010–2016Patents assigned to PFIZER (9)· patent assignee history
2012–2014Patents assigned to CUI JINGRONG JEAN (4)· patent assignee history
2012–2014Patents assigned to SHEN HONG (3)· patent assignee history
2016–2019Based in Beijing, CN· patent location history
2017–2019Patents assigned to TP THERAPEUTICS INC (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SUGEN INC122003–2007
PFIZER92010–2016
CUI JINGRONG JEANself42012–2014
TP THERAPEUTICS INC42017–2019
SHEN HONG32012–2014
Locations
LocationPatentsSpan
San Diego, California, US212006–2020
Foster City, California, US72003–2006
Beijing, CN22016–2019
Albany, California, US12005